South Korea has also shortened the booster shot interval to three months after the second jab. The Food and Drug Administration has given emergency authorization for 16- and 17-year-olds to get a Pfizer/BioNTech booster shot. It says benefits of boosters greatly outweigh the potential risk from rare side effects. Jack Barton now joins us from Seoul.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3